Skip to main content

MoneyWorks4Me

Indrayani Biotech informs about disclosure

20 Sep 2025 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, BSE has issued In-principle approval vide Ref: LOD/RIGHT/TT/FIP/920/2025-26 dated 19th September, 2025 for the proposed Right Issue; Indrayani Biotech has informed that the In-principle approval letter received from the Stock Exchange BSE is enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Grasim Industries 2963.45
DCM Shriram 874.70
3M India 28988.30
Hindustan Foods 534.75
Balmer Lawrie & Co 155.45
View more..